美股異動|應用材料盤前跌超5% 受出口管制影響全年營收約4億美元
半導體設備供應商應用材料(AMAT.US)盤前跌5.24%。消息上,公司公佈截至1月26日止首財季業績。季度淨利潤按年跌41%至11.85億美元,每股季度攤薄利潤1.45美元,經調整後爲2.38美元。季度淨收益按年升7%至71.66億美元,勝市場預期。公司預計現財季收入中位數71億美元,低於市場預期的72.1億美元;預測每股季度經調整攤薄利潤介乎2.12至2.48美元,中位數2.3美元,符合市場預期。公司表示,美國對中國收緊出口管制,將影響全年度收入約4億美元,半數在現季度反映。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.